PRODUCT
Product Description
SPTLC1 peptide is used for blocking the activity of SPTLC1 antibody (catalog number GTX32011).
APPLICATION
Application Note
*Optimal dilutions/concentrations should be determined by the researcher.
| Application |
Dilution |
| Assay dependent |
Not tested in other applications.
PROPERTIES
Form
Liquid
Buffer
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl), 0.1% BSA, 0.02% sodium azide
Storage
Store as concentrated solution. Aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.
Concentration
200 μg/ml (Please refer to the vial label for the specific concentration.)
Conjugation
Unconjugated
Note
For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
TARGET
Synonyms
Serine Palmitoyltransferase Long Chain Base Subunit 1 , Hsan1 , Hsn1 , Lbc1 , Lcb1 , Spt1 , Spti , Sptlc1
Background
Serine palmitoyltransferase, which consists of two different subunits, is the key enzyme in sphingolipid biosynthesis. It converts L-serine and palmitoyl-CoA to 3-oxosphinganine with pyridoxal 5'-phosphate as a cofactor. The product of this gene is the long chain base subunit 1 of serine palmitoyltransferase. Mutations in this gene were identified in patients with hereditary sensory neuropathy type 1. Alternatively spliced variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
REFERENCE
There are currently no references for SPTLC1 blocking peptide (GTX32011-PEP). Be the first to share your publications with this product.
REVIEW
There are currently no reviews for SPTLC1 blocking peptide (GTX32011-PEP). Be the first to share your experience with this product.
